| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Ophthalmology, 6 Neuroscience, and 7 Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland; the 2 Research Division and 4 Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts; the 5 Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and 3 Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
PURPOSE. To determine the effect of pigment epithelium-derived factor (PEDF) in a mouse model of ischemia-induced retinal neovascularization and on vascular endothelial growth factor (VEGF)–induced migration and growth of cultured microvascular endothelial cells.
METHODS. Human recombinant PEDF was expressed in the human embryonic kidney 293 cell line and purified by ammonium sulfate precipitation and cation exchange chromatography. C57BL/6 mice were exposed to 75% oxygen from postnatal day (P)7 to P12 and then returned to room air. Mice received intravitreal injections of 2 µg PEDF in one eye and vehicle in the contralateral eye on P12 and P14. At P17, mice were killed and eyes enucleated for quantitation of retinal neovascularization. The mitogenic and motogeneic effects of VEGF on cultured bovine retinal and adrenal capillary endothelial cells were examined in the presence or absence of PEDF, using cell counts and migration assays.
RESULTS. Two species of human recombinant PEDF, denoted A and B, were purified to apparent homogeneity. PEDF B appeared to comigrate on SDS-PAGE with PEDF from human vitreous samples. Changes in electrophoretic mobility after peptide-N-glycosidase F (PNGase F) digestion suggest that both PEDF forms contain N-linked carbohydrate. Analyses of the intact proteins by liquid chromatography–electrospray mass spectrometry (LC-ESMS) revealed the major molecular weight species for PEDF A (47,705 ± 4) and B (46,757 ± 5). LC-ESMS analysis of tryptic peptides indicated that PEDF A and B exhibit differences in glycopeptides containing N-acetylneuraminic acid (NeuAc) and N-acetylhexosamine (HexNAc). Intravitreal administration of either species of PEDF significantly inhibited retinal neovascularization (83% for PEDF A and 55% for PEDF B; P = 0.024 and 0.0026, respectively). PEDF A and B (20 nM) suppressed VEGF-induced retinal microvascular endothelial cell proliferation by 48.8% and 41.4%, respectively, after 5 days (P < 0.001) and VEGF-induced migration by 86.5% ± 16.7% and 78.1% ± 22.3%, respectively, after 4 hours (P = 0.004 and P = 0.008, respectively).
CONCLUSIONS. These data indicate that elevated concentrations of PEDF inhibit VEGF-induced retinal endothelial cell growth and migration and retinal neovascularization. These findings suggest that localized administration of PEDF may be an effective approach for the treatment of ischemia-induced retinal neovascular disorders.
This article has been cited by other articles:
|
|
 |
|
  J. Lange, Y. Yafai, A. Reichenbach, P. Wiedemann, and W. Eichler Regulation of Pigment Epithelium-Derived Factor Production and Release by Retinal Glial (Muller) Cells under Hypoxia Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5161 - 5167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Kang, H.-H. Park, S. Won Chae, S. J. Hwang, S. H. Lee, S. H. Lee, and H.-M. Lee Increased Expression of Pigment Epithelium-Derived Factor in Allergic Rhinitis Arch Otolaryngol Head Neck Surg, October 1, 2008; 134(10): 1094 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Bhutto, K. Uno, C. Merges, L. Zhang, D. S. McLeod, and G. A. Lutty Reduction of Endogenous Angiogenesis Inhibitors in Bruch's Membrane of the Submacular Region in Eyes With Age-Related Macular Degeneration Arch Ophthalmol, May 1, 2008; 126(5): 670 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Steinle, S. Sharma, and V. C. Chin Normal Aging Involves Altered Expression of Growth Factors in the Rat Choroid J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 135 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yoshida, S.-i. Yamagishi, T. Matsui, K. Nakamura, T. Imaizumi, K. Yoshimura, and R. Yamakawa Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy Br. J. Ophthalmol., September 1, 2007; 91(9): 1133 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yokoi, S.-i. Yamagishi, A. Saito, Y. Yoshida, T. Matsui, W. Saito, S. Hirose, K. Ohgami, M. Kase, and S. Ohno Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy Br. J. Ophthalmol., July 1, 2007; 91(7): 885 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakamura, S.-i. Yamagishi, T. Matsui, T. Yoshida, K. Takenaka, Y. Jinnouchi, Y. Yoshida, S.-i. Ueda, H. Adachi, and T. Imaizumi Pigment Epithelium-Derived Factor Inhibits Neointimal Hyperplasia after Vascular Injury by Blocking NADPH Oxidase-Mediated Reactive Oxygen Species Generation Am. J. Pathol., June 1, 2007; 170(6): 2159 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoshida, S.-i. Yamagishi, T. Matsui, K. Nakamura, T. Imaizumi, K. Yoshimura, and R. Yamakawa Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis Br. J. Ophthalmol., June 1, 2007; 91(6): 737 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Storey and J. M. Storey Tribute to P. L. Lutz: putting life on `pause' - molecular regulation of hypometabolism J. Exp. Biol., May 15, 2007; 210(10): 1700 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoshida, S.-i. Yamagishi, T. Matsui, K. Nakamura, T. Imaizumi, K. Yoshimura, and R. Yamakawa Increased levels of pigment epithelium-derived factor in aqueous humor of patients with uveitis Br. J. Ophthalmol., February 1, 2007; 91(2): 149 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Notari, V. Baladron, J. D. Aroca-Aguilar, N. Balko, R. Heredia, C. Meyer, P. M. Notario, S. Saravanamuthu, M.-L. Nueda, F. Sanchez-Sanchez, et al. Identification of a Lipase-linked Cell Membrane Receptor for Pigment Epithelium-derived Factor J. Biol. Chem., December 8, 2006; 281(49): 38022 - 38037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Yamagishi, K. Nakamura, T. Matsui, Y. Inagaki, K. Takenaka, Y. Jinnouchi, Y. Yoshida, T. Matsuura, I. Narama, Y. Motomiya, et al. Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression J. Biol. Chem., July 21, 2006; 281(29): 20213 - 20220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Yamagishi, H. Adachi, A. Abe, T. Yashiro, M. Enomoto, K. Furuki, A. Hino, Y. Jinnouchi, K. Takenaka, T. Matsui, et al. Elevated Serum Levels of Pigment Epithelium-Derived Factor in the Metabolic Syndrome J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2447 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Wang, S. X. Zhang, R. Mott, R. R. Knapp, W. Cao, K. Lau, and J.-x. Ma Salutary Effect of Pigment Epithelium-Derived Factor in Diabetic Nephropathy: Evidence for Antifibrogenic Activities Diabetes, June 1, 2006; 55(6): 1678 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Campochiaro and the First ARVO/Pfizer Institute Working Group Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 462 - 474. [Full Text] [PDF]
|
|
|
|
|
|
J. Amaral, R. N. Fariss, M. M. Campos, W. G. Robison Jr, H. Kim, R. Lutz, and S. P. Becerra Transscleral-RPE Permeability of PEDF and Ovalbumin Proteins: Implications for Subconjunctival Protein Delivery Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4383 - 4392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Kerrison, E. J. Duh, Y. Yu, D. C. Otteson, and D. J. Zack A System for Inducible Gene Expression in Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2932 - 2939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kanda, Y. Mochizuki, T. Nakamura, Y. Miyata, T. Matsuyama, and H. Kanetake Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn J. Cell Sci., March 1, 2005; 118(5): 961 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Gardiner, D. S. Gibson, T. E. de Gooyer, V. F. de la Cruz, D. M. McDonald, and A. W. Stitt Inhibition of Tumor Necrosis Factor-{alpha} Improves Physiological Angiogenesis and Reduces Pathological Neovascularization in Ischemic Retinopathy Am. J. Pathol., February 1, 2005; 166(2): 637 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Apte, R. A. Barreiro, E. Duh, O. Volpert, and T. A. Ferguson Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4491 - 4497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Franklin, T. L. Jetton, C. L. Kuchemann, S. R. Russell, and E. C. Kohn CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3756 - 3766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Maar, A. Luksch, A. Graebe, E. Ergun, B. Wimpissinger, M. Tittl, P. Vecsei, M. Stur, and L. Schmetterer Effect of Laser Photocoagulation on the Retinal Vessel Diameter in Branch and Macular Vein Occlusion Arch Ophthalmol, July 1, 2004; 122(7): 987 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Matsuoka, N Ogata, T Otsuji, T Nishimura, K Takahashi, and M Matsumura Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy Br. J. Ophthalmol., June 1, 2004; 88(6): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, J.-G. Ren, W. L. Cooper, C. E. Hawkins, M. R. Cowan, and P. Y. Tong Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site PNAS, April 27, 2004; 101(17): 6605 - 6610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abe, T. Shimizu, S.-i. Yamagishi, A. Shibaki, S. Amano, Y. Inagaki, H. Watanabe, H. Sugawara, H. Nakamura, M. Takeuchi, et al. Overexpression of Pigment Epithelium-Derived Factor Decreases Angiogenesis and Inhibits the Growth of Human Malignant Melanoma Cells in Vivo Am. J. Pathol., April 1, 2004; 164(4): 1225 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takita, S. Yoneya, P. L. Gehlbach, E. J. Duh, L. L. Wei, and K. Mori Retinal Neuroprotection against Ischemic Injury Mediated by Intraocular Gene Transfer of Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4497 - 4504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Oshima, C. Shukunami, J. Honda, K. Nishida, F. Tashiro, J.-i. Miyazaki, Y. Hiraki, and Y. Tano Expression and Localization of Tenomodulin, a Transmembrane Type Chondromodulin-I-Related Angiogenesis Inhibitor, in Mouse Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1814 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Barreiro, R. Schadlu, J. Herndon, H. J. Kaplan, and T. A. Ferguson The Role of Fas-FasL in the Development and Treatment of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1282 - 1286. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
